M47.26 M51.1
Conditions
Interventions
Group 1: Patients with single-level lumbar facet joint arthritis and corresponding chronic low back pain.
Patients receive a CT-guided bilateral facet joint infiltration of the affected segment with
Sponsors
Universitätsklinikum Jena
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria were patients aged > 18 years with predominantly lumbar back pain or predominantly monoradicular leg pain after the failure of structured non-invasive conservative treatment with pain relievers and physiotherapy for at least six weeks and a complaint duration of at least 12 weeks. In patients with predominantly unilateral lumbar radiculopathy based on an imaged-morphologically (MR-tomographically) secured monosegmental nerve root compression (caused by a herniated disc, stenosis of the lateral recess or neuroforamen), a PRI was performed. In patients with predominantly lumbar pain based on an imaged-morphologically (MR-tomographically) secured monosegmental lumbar segment degeneration (intervertebral disc degeneration, osteochondrosis, degenerative spondylolisthesis) with spondylarthrosis with Fujiwara grade >= 3 °, an FGI was performed. All patients were mentally and physically capable of declaring consent and processing the questionnaires.
Exclusion criteria
Exclusion criteria: Exclusion criteria were previous surgeries on the affected spine segment, multisegmental pathologies in the MRI of the lumbar spine, as well as bilateral radicular complaints. Furthermore, patients in whom the peri-interventional risk profile was increased due to other diseases were excluded. These included insufficiently controlled diabetes mellitus, intake of oral anticoagulants, clotting disorders, increased laboratory infection parameters (leukocytosis, increased CRP), and known infections and/or cancer diseases. Patients who had an absolute surgical indication due to acute serious neurological deficits (e.g. paresis > 3/5 according to Janda, conus / cauda syndrome) were also excluded from the study. In addition, patients who could not meet the requirements for telephone interviews were excluded from the study, as were patients with a known allergy to local anesthetics (LA) or corticosteroids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endpoints were improvement of pain (NRS) and function (Oswestry disability Index) with regard to Minimally Clinically Important Difference (MCID) at time points: postinterventionally, 6 weeks, 3, 6, 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of satisfaction (McNab) and HrQoL at 1 year. | — |
Countries
Germany
Contacts
Public ContactChris Lindemann
Waldkliniken Eisenberg
Outcome results
None listed